Trial intelligence / Profile preview

Cationorm for Symptoms After Pterygium Surgery

NCT07064187Phase 4Completed

Start
Jun 2022
Primary completion
Aug 2022
Modality
Nanoparticles
Countries
1
01

Overview

A Phase 4 trial of cationorm in Ocular discomfort. Started Jun 2022; status: completed.

02

Drugs

cationorm
03

Conditions

Ocular discomfort

Beyond the preview

Go deeper on NCT07064187.

Study design, results and competitive context are available in the Gosset platform where reported.

Study design & results

Available in the Gosset platform where reported.

Competitive context

Available in the Gosset platform where reported.

Bring the full picture into focus.

See how Gosset can support your research on NCT07064187.

Gosset Free

Get started with Gosset.

Enter your corporate email.

Work email preferred.

Book a call